Returning to the source of disease treatment the reform of drug field in China will be speeded up

[China Pharmaceutical network policies and regulations] a drug, from the initial production to the hands of patients, involves production, circulation, use and other links At present, the problem of high drug price makes many patients unable to see the disease, which is largely due to the circulation link In the traditional field of drug distribution, the characteristics of market dispersion, local separatism and disordered distribution channels have existed for a long time On January 25, the Information Office of the State Council held a briefing on Several Opinions on further reform and improvement of drug production, circulation and use policies (hereinafter referred to as "several opinions") Wang Hesheng, deputy director of the national health and Family Planning Commission, said at the meeting that the State Council would formally issue several opinions in the near future (Wang Hesheng, deputy director of national health and Family Planning Commission) Wang Hesheng pointed out that "several opinions" involve all aspects of drug production, circulation and use, which is a major reform policy of the whole chain and whole process in the field of drugs It can improve the ability of drug research and development and innovation, improve the quality and efficacy of drugs, standardize the order of drug production and circulation, guarantee the production and supply of drugs, promote rational drug use, reduce the virtual high price of drugs, and reduce the whole society It is of great significance to meet the medical expenses burden, promote the supply side structural reform of the pharmaceutical industry, accelerate the industrial transformation and upgrading, and promote the construction of a healthy China Several opinions pointed out that the key to production is to improve the quality and efficacy of drugs First, we will strictly review and approve the listing of drugs, optimize the review and approval procedures, and promote information disclosure Second, accelerate the consistency evaluation of quality and efficacy of listed generic drugs, and provide policy support for drugs passing the consistency evaluation Third, we will orderly promote the pilot of the listing permit holder system and encourage new drug research and development Fourth, strengthen the supervision of drug production quality and safety, and crack down on the illegal and criminal acts of manufacturing and selling fake and inferior drugs Fifthly, we will increase the restructuring of the pharmaceutical industry and push backward enterprises to exit Sixthly, we will improve the mechanisms for monitoring, early warning and grading response of drugs in short supply and at low prices, so as to ensure the effective supply of drugs According to several opinions, we should focus on rectifying the circulation order and reforming and improving the circulation system First, promote the transformation and upgrading of drug distribution enterprises and improve the drug distribution network in urban and rural areas Second, we will implement the "two vote system" for drug purchase and sale and strive to push it across the country by 2018 Third, we will implement the policy of classified purchase of drugs and reduce the inflated prices of drugs Fourth, we should strengthen the management of drug purchase and sale contracts, and bear corresponding penalties for violation of the contract Fifthly, we should rectify the outstanding problems in the field of drug circulation, severely punish illegal enterprises, medical institutions and relevant responsible personnel according to law, and record them in the bad credit records Sixth, establish the traceability mechanism of drug price information to promote the transparency of price information Seven, we should give full play to the advantages and functions of "Internet plus drug circulation", so as to facilitate the public to use drugs Several opinions stressed that in the use process, we should reform and adjust the interest driven mechanism to make drugs return to the source of treatment First, public hospitals should give priority to the use of national essential drugs, strengthen the supervision of drug use, and promote rational use of drugs; second, we should further break the mechanism of supplementing medical treatment with drugs, and strictly control the unreasonable growth of medical expenses; third, we should strengthen the role of medical insurance in regulating behaviors and controlling expenses, vigorously promote the reform of medical insurance payment mode, and promote medical institutions to actively regulate medical behaviors; fourth, we should actively play drugs The role of teachers in rational drug use "After the promulgation and implementation of several opinions, it will bring tangible well-being to the masses." Wang Hesheng pointed out that after implementation, the quality of drugs will be more safe, the price of drugs will be more reasonable, the supply of drugs will be more secure and the use of drugs will be more standardized.